Who Paid My Doc
A Phase 3, Multicenter, Open-Label Study to Evaluate the Safety and Immunogenicity of 2-dose Regimens of 9vHPV and mRNA-1273 SARS-CoV-2 Vaccines Where the First Dose of Each Vaccine Are Given Concomitantly in Boys and Girls 9 to 11 Years of Age
Research payments
$6,344,237
Through program year 2024, $6,344,237 in research payments was reported against A Phase 3, Multicenter, Open-Label Study to Evaluate the Safety and Immunogenicity of 2-dose Regimens of 9vHPV and mRNA-1273 SARS-CoV-2 Vaccines Where the First Dose of Each Vaccine Are Given Concomitantly in Boys and Girls 9 to 11 Years of Age, across 280 payments, paid by Merck Sharp & Dohme Corporation.
- Paid by
- Merck Sharp & Dohme Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $357,875 | 36 |
| 2023 | Research | $1,573,149 | 94 |
| 2022 | Research | $3,887,681 | 114 |
| 2021 | Research | $525,531 | 36 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
9 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Celia Reyes-Acuna Corpus Christi, TX Named on 9 payments
- Christopher Smith Horseheads, NY Named on 6 payments
- Natasha Ballard Chattanooga, TN Named on 5 payments
- Hector Cordero Naples, FL Named on 5 payments
- Kevin Rouse Jonesboro, AR Named on 5 payments
- Masoud Azizad Northridge, CA Named on 4 payments
- Bruce Rankin Deland, FL Named on 4 payments
- Elia Acevedo-Diaz Boston, MA Named on 4 payments
- Apinya Vutikullird Cypress, CA Named on 4 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.